RH: consultant to Takeda R&D Europe and have been a speaker for Takeda symposia also
a consultant to Novartis and Insys. DA: consulted with Pfizer on PPI therapy, after completion …

In Japan, with the increasing prevalence of gastroesophageal reflux disease (GERD) and
growing public interest, the Japanese Society of Gastroenterology issued Evidence-based …

Abstract Background and Aims: Since the publication of the Asia‐Pacific GERD consensus
in 2004, more data concerning the epidemiology and management of gastroesophageal …

Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

As an increase in gastroesophageal reflux disease (GERD) has been reported in Japan,
and public interest in GERD has been increasing, the Japanese Society of Gastroenterology …

Objective Since the publication of the Asia-Pacific consensus on gastro-oesophageal reflux
disease in 2008, there has been further scientific advancement in this field. This updated …

Guidelines for the diagnosis and treatment of gastroesophageal reflux disease (GERD) were
published by the American College of Gastroenterology in 1995 (1). These and other …

OBJECTIVES A globally acceptable definition and classification of gastroesophageal reflux
disease (GERD) is desirable for research and clinical practice. The aim of this initiative was …

1. Demonstrate an understanding of the natural history and manifestations of reflux disease
2. Evaluate the role of diagnostic testing such as endoscopy, esophageal manometry …

BACKGROUND: Gastroesophageal reflux disease (GERD) is the most prevalent acid‐
related disorder in Canada and is associated with significant impairment of health‐related …